Sustainable Biotech Xylome focuses on sustainable ingredient replacements such as a white palm oil bio-identical and fish oil bio-identical substitutes, presenting sales opportunities with consumer goods, nutraceuticals, and feed industries seeking greener inputs.

High-Value Delivery Lipids-based technology enables hydrophobic drug delivery and topical pharmaceutical products, offering potential partnerships or contract work with pharma companies aiming to improve formulation performance or expand to high-value therapies.

Antifungal Program Internal antifungal program for severe burns in collaboration with the University of Wisconsin signals a path to licensing deals or co-development with medical institutions and biotech or pharma partners targeting burn care and infection management.

SBIR and Awards Regular recognition at SBIR showcases and international aquaculture awards indicate strong program credibility; leverage these to approach government contractors, grant-funded projects, and innovation-focused customers seeking proven research partners.

Scale and Partnerships Revenue and modest funding levels suggest a need for strategic partnerships to scale capabilities; target collaborations with larger biotech firms, contract manufacturers, and sustainable ingredient producers to accelerate reach and commercialization.